|
Patent no.
|
Date of issue
|
Assignee
|
Componds
|
Ref.
|
| EP1755388B1 |
6 Oct, 2010 |
TransForm Pharmaceuticals, Inc. |
Mixed cocrystals of modafinil |
61 |
| EP2185546B1 |
26 Oct, 2011 |
Vertex Pharmaceuticals, Inc. |
Cocrystals and pharmaceutical compositions, telaprevir (VX-950) |
62 |
| EP2334687B1 |
4 Jan, 2012 |
Pfizer Inc. |
SGLT-2 inhibitors, l-proline and pyroglutamic acid cocrystals |
63 |
| EP2300472B1 |
18 Jan, 2012 |
Boehringer Ingelheim Intl. GmBH |
Glucocorticoid analogs, phosphoric acid and acetic acid cocrystals |
64 |
| EP2114924B1 |
25 Jan, 2012 |
Vertex Pharmaceuticals Inc. |
Cocrystals of telaprevir with 4-hydroxybenzoic acid; solvates |
65 |
| EP2288606B1 |
15 Feb, 2012 |
Bayer Pharma Ag |
Rivaroxaban cocrystal with malonic acid |
66 |
| EP1608339B1 |
21 Mar, 2012 |
McNeil PPC |
Celecoxib cocrystal with nicotinamide |
67 |
| EP3210975 A1 |
30 Aug, 2017 |
Enantia, S.L. |
Cocrystals of Lorcaserin hydrochloride and an organic diacid |
68 |
| EP3240575 A1 |
8 Nov, 2017 |
Dr. Reddy's Laboratories Ltd. |
co-crystal of carfilzomib with maleic acid |
69 |
